Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
Merck
Colorcon
Mallinckrodt

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide; reserpine - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of patent protection?

Hydralazine hydrochloride; hydrochlorothiazide; reserpine is the generic ingredient in twelve branded drugs marketed by Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Watson Labs, Sandoz, Solvay, Sun Pharm Industries, Lederle, and Novartis, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for hydralazine hydrochloride; hydrochlorothiazide; reserpine.

Summary for hydralazine hydrochloride; hydrochlorothiazide; reserpine
Recent Clinical Trials for hydralazine hydrochloride; hydrochlorothiazide; reserpine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentN/A

See all hydralazine hydrochloride; hydrochlorothiazide; reserpine clinical trials

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087556-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lederle RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087709-001 May 13, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085549-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
McKinsey
Express Scripts
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.